Home
Scholarly Works
P2.13-13 Real-World Study of Osimertinib in EGFR...
Conference

P2.13-13 Real-World Study of Osimertinib in EGFR T790M-Mutated Non-Small Cell Lung Cancer (NSCLC): ASTRIS Canadian Cohort Analysis

Authors

Cheema P; Liu G; Burkes R; Owen S; Yu J; Hao D; Rothenstein J; Martel S; Iqbal M; Juergens R

Volume

13

Publisher

Elsevier

Publication Date

October 1, 2018

DOI

10.1016/j.jtho.2018.08.1408

Conference proceedings

Journal of Thoracic Oncology

Issue

10

ISSN

1556-0864

Contact the Experts team